• About
    Mission and HistoryExpertsIndependence and TransparencyInternships/Research Fellows
  • Explore Our WorkExplore Our Work
    • Our Work
      • Work
        • Amicus Briefs
        • Diversity and Inclusion
        • Economic & Policy Analysis
        • Fair Fight Film
        • Grant Research
        • Legal Analysis
        • Podcasts
        • Public Comments and Testimony
        • Reports
      • Issues By Sector
        • Airlines
        • Banking & Finance
        • Digital Technology
        • Energy
        • Food & Agriculture
        • Health & Pharmaceuticals
        • Innovation & Entrepreneurship
        • Intellectual Property
        • International
        • Labor
        • Media & Communications
        • Retail & Distribution
        • Transportation
      • Issues By Enforcement Area
        • Buyer Power
        • Cartels
        • Collusion
        • Exemptions & Immunities
        • Mergers
        • Monopolies
        • Private Enforcement
        • Public Enforcement
  • Events
  • Awards
    Alfred E. Kahn Award for Antitrust AchievementAntitrust Enforcement AwardsPrivate Antitrust Enforcement Hall of FameHollis Salzman Memorial Leadership AwardJerry S. Cohen Award for Antitrust Scholarship (administered by Cohen Milstein and hosted by AAI)
  • CLE Programs
  • Support
    Supporting AAIDonateSponsorshipsCy PresGrants
Working Papers

AAI Working Paper No. 09-06: Cartels and Antitrust Portrayed: Private International Cartels from 1990 to 2008

September 1, 2009 | John M. Connor
Cartels , Collusion , Competition Policy , International , Horizontal Restraints , Private Enforcement

Purdue Economist and AAI Senior Fellow John Connor provides this extensive collection of graphs profiling 516 hard-core international cartels that were subject to government or private legal actions.

Working Paper No. 9-06

Related Work

In The News

FTC Commissioners Cite AAI Study on Private Equity in Healthcare in Support of Merger Action

June 16, 2022
Competition Policy , FTC , Health & Pharmaceuticals , Mergers , Private Equity , Section 7 of the Clayton Act
Podcasts

From Medical Licensing to Health Insurance: Major Policy Issues That Will Shape the Future of Telehealth

June 13, 2022 | Diana L. Moss, Kim Horvath, Jenna Milaeger
Competition Policy , Health & Pharmaceuticals , Innovation
Economic & Policy Analysis

AAI President and Advisors to Speak at June 14-15 Federal Trade Commission/U.S. Dept. of Justice Workshop on Enforcing the Antitrust Laws in the Pharmaceutical Industry

June 9, 2022 | Diana L. Moss
Public Enforcement , Health & Pharmaceuticals , Private Enforcement , Collusion
Podcasts

The High Costs of Growing Corn: How Growers are Squeezed by High Input Prices That Are Set by the Fertilizer Oligopoly

May 24, 2022 | Diana L. Moss, Dee Vaughan, Dr. Joe Outlaw
Food & Agriculture , Collusion , International

Support AAI

Promoting competition that protects consumers, businesses, and society is more important than ever. Through our research, education, and advocacy programs, AAI has been active in focusing public and private competition enforcement priorities and shaping progressive competition policy. The only way for AAI to fulfill its mission is through your support.

Learn More

Address

1025 Connecticut Avenue, NW
Suite 1000
Washington, DC 20036
(202) 828-1226

Join Our Mailing List

    • About
    • Terms of Use
    • Contact Us
    • Support

    Copyright © American Antitrust Institute 2022